Secora Michael's most recent trade in Recursion Pharmaceuticals Inc - Ordinary Shares - Class A was a trade of 11,937 Class A Common Stock done at an average price of $6.2 . Disclosure was reported to the exchange on Nov. 15, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.18 per share. | 15 Nov 2024 | 11,937 | 1,487,694 | - | 6.2 | 73,711 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 12 Nov 2024 | 39,375 | 1,490,256 | - | 2.2 | 87,413 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2024 | 39,375 | 337,635 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2024 | 39,375 | 377,010 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 12 Nov 2024 | 39,375 | 1,514,631 | - | 2.2 | 87,413 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.66 per share. | 12 Nov 2024 | 15,000 | 1,499,631 | - | 7.7 | 114,876 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.64 per share. | 12 Nov 2024 | 15,000 | 1,475,256 | - | 7.6 | 114,629 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 08 Oct 2024 | 39,375 | 1,441,506 | - | 2.2 | 87,413 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2024 | 39,375 | 416,385 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2024 | 39,375 | 455,760 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 08 Oct 2024 | 39,375 | 1,465,881 | - | 2.2 | 87,413 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.36 per share. | 08 Oct 2024 | 15,000 | 1,450,881 | - | 6.4 | 95,375 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.32 per share. | 08 Oct 2024 | 15,000 | 1,426,506 | - | 6.3 | 94,757 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 39,375 | 495,135 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2024 | 39,375 | 534,510 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 10 Sep 2024 | 39,375 | 1,417,131 | - | 2.2 | 87,413 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 10 Sep 2024 | 39,375 | 1,392,756 | - | 2.2 | 87,413 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.32 per share. | 10 Sep 2024 | 15,000 | 1,402,131 | - | 6.3 | 94,730 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.17 per share. | 10 Sep 2024 | 15,000 | 1,377,756 | - | 6.2 | 92,499 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.69 per share. | 15 Aug 2024 | 11,962 | 1,353,381 | - | 6.7 | 80,026 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 39,375 | 573,885 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2024 | 39,375 | 613,260 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 13 Aug 2024 | 39,375 | 1,380,343 | - | 2.2 | 87,413 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 13 Aug 2024 | 39,375 | 1,355,968 | - | 2.2 | 87,413 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.35 per share. | 13 Aug 2024 | 15,000 | 1,365,343 | - | 6.4 | 95,252 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.35 per share. | 13 Aug 2024 | 15,000 | 1,340,968 | - | 6.3 | 95,183 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2024 | 39,375 | 692,010 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2024 | 39,375 | 652,635 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 09 Jul 2024 | 39,375 | 1,307,218 | - | 2.2 | 87,413 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 09 Jul 2024 | 39,375 | 1,331,593 | - | 2.2 | 87,413 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.32 per share. | 09 Jul 2024 | 15,000 | 1,292,218 | - | 7.3 | 109,778 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.24 per share. | 09 Jul 2024 | 15,000 | 1,316,593 | - | 7.2 | 108,576 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2024 | 39,375 | 731,385 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 13 Jun 2024 | 39,375 | 1,282,843 | - | 2.2 | 87,413 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2024 | 39,375 | 770,760 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 13 Jun 2024 | 39,375 | 1,258,468 | - | 2.2 | 87,413 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.27 per share. | 13 Jun 2024 | 15,000 | 1,267,843 | - | 9.3 | 139,082 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.32 per share. | 13 Jun 2024 | 15,000 | 1,243,468 | - | 9.3 | 139,799 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.01 per share. | 15 May 2024 | 11,962 | 1,219,093 | - | 10.0 | 119,740 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2024 | 37,500 | 810,135 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 16 Apr 2024 | 37,500 | 1,254,179 | - | 2.2 | 83,250 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 16 Apr 2024 | 37,500 | 1,241,679 | - | 2.2 | 83,250 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2024 | 37,500 | 847,635 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.67 per share. | 16 Apr 2024 | 25,000 | 1,216,679 | - | 7.7 | 191,658 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.58 per share. | 16 Apr 2024 | 23,124 | 1,231,055 | - | 7.6 | 175,349 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 12 Mar 2024 | 37,500 | 1,229,179 | - | 2.2 | 83,250 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 12 Mar 2024 | 37,500 | 1,216,679 | - | 2.2 | 83,250 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2024 | 37,500 | 922,635 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2024 | 37,500 | 885,135 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.46 per share. | 12 Mar 2024 | 25,000 | 1,191,679 | - | 10.5 | 261,375 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.03 per share. | 12 Mar 2024 | 25,000 | 1,204,179 | - | 11.0 | 275,815 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.43 per share. | 15 Feb 2024 | 7,172 | 1,179,179 | - | 12.4 | 89,148 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 13 Feb 2024 | 37,500 | 1,211,351 | - | 2.2 | 83,250 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 37,500 | 960,135 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Secora Michael | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 13 Feb 2024 | 37,500 | 1,198,851 | - | 2.2 | 83,250 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2024 | 37,500 | 997,635 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Secora Michael | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.86 per share. | 13 Feb 2024 | 25,000 | 1,173,851 | - | 9.9 | 246,560 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.43 per share. | 13 Feb 2024 | 23,933 | 1,187,418 | - | 10.4 | 249,705 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Secora Michael | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.98 per share. | 13 Feb 2024 | 1,067 | 1,186,351 | - | 11.0 | 11,720 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 348,380 | 348,380 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 174,190 | 1,163,863 | - | 0 | Class A Common Stock | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 8,659 | 989,673 | - | 0 | Class A Common Stock | |
| Recursion Pharma Inc (Class A) | Secora Michael | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.09 per share. | 09 Feb 2024 | 2,512 | 1,161,351 | - | 10.1 | 25,346 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Secora Michael | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 16 Jan 2024 | 37,500 | 1,006,014 | - | 2.2 | 83,250 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Secora Michael | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 16 Jan 2024 | 37,500 | 993,514 | - | 2.2 | 83,250 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Secora Michael | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2024 | 37,500 | 1,035,135 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Secora Michael | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2024 | 37,500 | 1,072,635 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Secora Michael | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.45 per share. | 16 Jan 2024 | 25,000 | 968,514 | - | 10.4 | 261,160 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.25 per share. | 16 Jan 2024 | 25,000 | 981,014 | - | 10.3 | 256,348 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Secora Michael | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 12 Dec 2023 | 37,500 | 981,014 | - | 2.2 | 83,250 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Secora Michael | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 12 Dec 2023 | 37,500 | 968,514 | - | 2.2 | 83,250 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2023 | 37,500 | 1,110,135 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Secora Michael | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2023 | 37,500 | 1,147,635 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Secora Michael | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.59 per share. | 12 Dec 2023 | 25,000 | 956,014 | - | 7.6 | 189,770 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Secora Michael | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.39 per share. | 12 Dec 2023 | 25,000 | 943,514 | - | 7.4 | 184,868 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 15 Aug 2023 | 37,500 | 888,186 | - | 2.2 | 83,250 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 15 Aug 2023 | 37,500 | 875,686 | - | 2.2 | 83,250 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 37,500 | 1,410,135 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 37,500 | 1,485,135 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.27 per share. | 15 Aug 2023 | 25,000 | 850,686 | - | 9.3 | 231,793 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.90 per share. | 15 Aug 2023 | 25,000 | 863,186 | - | 8.9 | 222,518 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.19 per share. | 15 Aug 2023 | 4,727 | 838,186 | - | 9.2 | 43,441 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 18 Jul 2023 | 37,500 | 855,413 | - | 2.2 | 83,250 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jul 2023 | 37,500 | 670,313 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jul 2023 | 37,500 | 707,813 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 18 Jul 2023 | 37,500 | 867,913 | - | 2.2 | 83,250 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 13.62 per share. | 18 Jul 2023 | 24,500 | 830,913 | - | 13.6 | 333,778 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.36 per share. | 18 Jul 2023 | 13,150 | 852,772 | - | 15.4 | 202,018 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.00 per share. | 18 Jul 2023 | 9,859 | 842,913 | - | 16.0 | 157,734 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.36 per share. | 18 Jul 2023 | 1,991 | 865,922 | - | 14.4 | 28,596 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.05 per share. | 18 Jul 2023 | 500 | 830,413 | - | 14.0 | 7,024 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 13 Jun 2023 | 37,500 | 830,413 | - | 2.2 | 83,250 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2023 | 37,500 | 745,313 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2023 | 37,500 | 782,813 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.22 per share. | 13 Jun 2023 | 37,500 | 842,913 | - | 2.2 | 83,250 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.93 per share. | 13 Jun 2023 | 25,000 | 805,413 | - | 9.9 | 248,308 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.07 per share. | 13 Jun 2023 | 25,000 | 817,913 | - | 10.1 | 251,838 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.60 per share. | 15 May 2023 | 4,760 | 790,159 | - | 5.6 | 26,656 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.44 per share. | 15 Feb 2023 | 1,258 | 794,310 | - | 8.4 | 10,618 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 404,857 | 404,857 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 202,428 | 790,502 | - | 0 | Class A Common Stock |